Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
The effects of i.v. chloramphenicol sodium succinate on the pharmacokinetics of i.v. phenylbutazone in six healthy adult horses were investigated. Administration of chloramphenicol sodium succinate to mares reduced mean (+/- SD) phenylbutazone clearance from 0.600 +/- 0.222 to 0.339 +/- 0.123 ml/min per kg and increased mean (+/- SD) half life from 244 +/- 59.8 to 371 +/- 80.8 min and mean residence time from 333 +/- 86.2 to 533 +/- 124 min. The mean steady-state volume of distribution of phenylbutazone was unchanged, with mean (+/- SD) values of 187 +/- 28.9 ml/kg in control animals and 170 +/- 32.4 ml/kg after chloramphenicol sodium succinate.
D000818:Animals; D001682:Biological Availability; D002701:Chloramphenicol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D005260:Female; D006736:Horses / Q000378:metabolism*; D007275:Injections, Intravenous; D010113:Oxyphenbutazone / Q000097:blood; D010653:Phenylbutazone / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D013997:Time Factors
D002701:Chloramphenicol; D010653:Phenylbutazone; D010113:Oxyphenbutazone; C026016:chloramphenicol succinate